Singapore - GSK
GSK was the first global healthcare company to establish a presence in Singapore in 1959. For over 60 years, GSK has been an important contributor to the healthcare system and the biopharma manufacturing sector in Singapore.
GSK plc today announced the opening of a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore. The opening of the facility was officiated by Guest-of-Honour, Singapore’s Minister for Health, Mr. Ong Ye Kung, and Mr. Regis Simard, GSK’s President, Global Supply Chain. The HPF will ...
GSK’s Tuas vaccine facility is Singapore’s largest after over ...
2023年7月13日 · SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned the title of Singapore’s largest vaccine production site based on a cumulative investment of some $850 million,...
GSK today celebrated the groundbreaking of its S$343 million state-of-the-art vaccines facility at Tuas which will manufacture drug substances for GSK’s vaccines that protect against Hepatitis B. This expansion of the existing GSK facility at Tuas will start construction in the third quarter of 2023, with completion targeted by 2025.
GSK’s Tuas vaccine facility is Singapore’s largest after S ...
The expansion of British drugmaker GSK’s facility at Tuas has earned it the title of Singapore’s largest vaccine production site based on a cumulative investment of some S$850 million, said Minister for Trade and Industry Gan Kim Yong.
GSK - Global Network
View All Singapore Japan Hong Kong Malaysia Thailand Indonesia Vietnam. ... GSK 15th Years Anniversary. More VDO. Close. News Update. 16-09-2021. GSK Chemical In ...
GSK invests S$343 million in state-of-the-art vaccines ...
Global biopharmaceutical powerhouse GSK is expanding its Tuas vaccines facility in Singapore and will begin producing drug substances for Hepatitis B vaccines when commercial production commences in 2027.
- 某些结果已被删除